BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30060095)

  • 1. Whole-Blood Transcriptional Signatures Composed of Erythropoietic and NRF2-Regulated Genes Differ Between Cerebral Malaria and Severe Malarial Anemia.
    Nallandhighal S; Park GS; Ho YY; Opoka RO; John CC; Tran TM
    J Infect Dis; 2019 Jan; 219(1):154-164. PubMed ID: 30060095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case-control study of African children.
    Erdman LK; Petes C; Lu Z; Dhabangi A; Musoke C; Cserti-Gazdewich CM; Lee CG; Liles WC; Elias JA; Kain KC
    Malar J; 2014 Jul; 13():279. PubMed ID: 25047113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum EPCR-binding PfEMP1 expression increases with malaria disease severity and is elevated in retinopathy negative cerebral malaria.
    Shabani E; Hanisch B; Opoka RO; Lavstsen T; John CC
    BMC Med; 2017 Oct; 15(1):183. PubMed ID: 29025399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Oxidative Stress on Risk of Death and Readmission in African Children With Severe Malaria: A Prospective Observational Study.
    Blatt DB; Hanisch B; Co K; Datta D; Bond C; Opoka RO; Cusick SE; Michelow IC; John CC
    J Infect Dis; 2022 Sep; 226(4):714-722. PubMed ID: 35678643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Plasma Tau With Mortality and Long-term Neurocognitive Impairment in Survivors of Pediatric Cerebral Malaria and Severe Malarial Anemia.
    Datta D; Bangirana P; Opoka RO; Conroy AL; Co K; Bond C; Zhao Y; Kawata K; Saykin AJ; John CC
    JAMA Netw Open; 2021 Dec; 4(12):e2138515. PubMed ID: 34889945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemia.
    Anyona SB; Kempaiah P; Raballah E; Davenport GC; Were T; Konah SN; Vulule JM; Hittner JB; Gichuki CW; Ong'echa JM; Perkins DJ
    Am J Hematol; 2012 Aug; 87(8):782-9. PubMed ID: 22730036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum.
    Kisia LE; Kempaiah P; Anyona SB; Munde EO; Achieng AO; Ong'echa JM; Lambert CG; Chelimo K; Ouma C; Perkins DJ; Raballah E
    BMC Med Genet; 2019 Aug; 20(1):140. PubMed ID: 31420016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods.
    Ong'echa JM; Davenport GC; Vulule JM; Hittner JB; Perkins DJ
    Infect Immun; 2011 Nov; 79(11):4674-80. PubMed ID: 21859849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Postdischarge Morbidity in Ugandan Children With Severe Malarial Anemia or Cerebral Malaria.
    Opoka RO; Hamre KES; Brand N; Bangirana P; Idro R; John CC
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e41-e48. PubMed ID: 28339598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined measurement of soluble and cellular ICAM-1 among children with Plasmodium falciparum malaria in Uganda.
    Cserti-Gazdewich CM; Dzik WH; Erdman L; Ssewanyana I; Dhabangi A; Musoke C; Kain KC
    Malar J; 2010 Aug; 9():233. PubMed ID: 20712868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 T-cell expression of IFN-γ and IL-17 in pediatric malarial anemia.
    Raballah E; Kempaiah P; Karim Z; Orinda GO; Otieno MF; Perkins DJ; Ong'echa JM
    PLoS One; 2017; 12(4):e0175864. PubMed ID: 28426727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe malarial anemia: innate immunity and pathogenesis.
    Perkins DJ; Were T; Davenport GC; Kempaiah P; Hittner JB; Ong'echa JM
    Int J Biol Sci; 2011; 7(9):1427-42. PubMed ID: 22110393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of mortality in 22 children with sickle cell anemia and severe malarial anemia.
    Opoka RO; Bangirana P; Idro R; Shabani E; Namazzi R; John CC
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28834130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen volume and clinical disease manifestations of severe Plasmodium falciparum malaria in African children.
    Kotlyar S; Nteziyaremye J; Olupot-Olupot P; Akech SO; Moore CL; Maitland K
    Trans R Soc Trop Med Hyg; 2014 May; 108(5):283-9. PubMed ID: 24639372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.
    Ouma C; Keller CC; Davenport GC; Were T; Konah S; Otieno MF; Hittner JB; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
    Infect Immun; 2010 Jan; 78(1):453-60. PubMed ID: 19884328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria.
    Aubouy A; Olagnier D; Bertin G; Ezinmegnon S; Majorel C; Mimar S; Massougbodji A; Deloron P; Pipy B; Coste A
    Malar J; 2015 Sep; 14():358. PubMed ID: 26385579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levels of CD16/Fc gamma receptor IIIA on CD14+ CD16+ monocytes are higher in children with severe Plasmodium falciparum anemia than in children with cerebral or uncomplicated malaria.
    Ogonda LA; Orago AS; Otieno MF; Adhiambo C; Otieno W; Stoute JA
    Infect Immun; 2010 May; 78(5):2173-81. PubMed ID: 20231419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial aggregation of cerebral malaria and severe malarial anemia.
    Ranque S; Safeukui I; Poudiougou B; Traoré A; Keita M; Traoré D; Diakité M; Cissé MB; Keita MM; Doumbo OK; Dessein AJ
    J Infect Dis; 2005 Mar; 191(5):799-804. PubMed ID: 15688298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood transcriptome of childhood malaria.
    Boldt ABW; van Tong H; Grobusch MP; Kalmbach Y; Dzeing Ella A; Kombila M; Meyer CG; Kun JFJ; Kremsner PG; Velavan TP
    EBioMedicine; 2019 Feb; 40():614-625. PubMed ID: 30638864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of iron status 28 d after provision of antimalarial treatment with iron therapy compared with antimalarial treatment alone in Ugandan children with severe malaria.
    Cusick SE; Opoka RO; Ssemata AS; Georgieff MK; John CC
    Am J Clin Nutr; 2016 Mar; 103(3):919-25. PubMed ID: 26843153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.